It could block the interaction between 3-methylcrotonyl-CoA carboxylase A (MCCA) and MCCB, inhibit Leu catabolism and activate mTORC1 signaling, thereby increasing the malignant phenotype of CCA cells. The gene discussed is MCCC1; the disease is cholangiocarcinoma.